Results
218
Annually loss-making mid-caps and large-caps with sound financial health.
218 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MRVI | US$8.42 | -0.2% | -15.8% | US$2.1b | US$11.27 | PS4.3x | E89.7% | n/a | Pharmaceuticals & Biotech | ||
PING | US$28.50 | 0.4% | 4.5% | US$2.5b | US$28.44 | PS8x | E5.5% | n/a | Software |